IngredientAI

Cover Block

PUBLIC

Attribute	Value
Company Name	IngredientAI
Tagline	AI platform surfacing insights from millions of studies to accelerate dietary supplement and functional food innovation.
Headquarters	New York, United States
Founded	2023
Stage	Pre-Seed
Business Model	SaaS
Industry	Healthtech
Technology	AI / Machine Learning
Geography	North America
Founding Team	Co-Founders (2)
Funding Label	Undisclosed

Table: Core company identifiers and classification. The founding team size and pre-seed stage are based on database profiles [PitchBook, 2026] [The Org, 2026]. The funding status is undiscosed across available sources.

Links

PUBLIC

• Website: https://www.ingredient-ai.com/
• LinkedIn: https://www.linkedin.com/company/ingredientai

Executive Summary

PUBLIC IngredientAI is an early-stage platform applying large-scale AI to a specific, high-friction problem: accelerating innovation in the dietary supplement and functional food industries by synthesizing insights from tens of millions of scientific studies [CRN USA, pre-2026]. The company aims to replace manual research and compliance verification with a software layer that promises to speed up formulation, ingredient discovery, and supplier matching for brands and manufacturers. Its initial wedge is a tool for compliant research and idea synthesis, with future surfaces planned for dossier generation and AI-powered supplier connections [Tola Capital, 2026].

The founding story is directly tied to the CEO's prior venture. Akash Shah, the co-founder and CEO, previously co-founded and served as CTO of the direct-to-consumer vitamin company Care/of, which raised $15 million in venture capital before shutting down in 2024 [TechCrunch, 2024] [Forbes, 2018]. This experience in the supplement space, including navigating the complex landscape of ingredient claims and compliance, forms the core of IngredientAI's thesis. The company appears to be bootstrapped or funded via an undisclosed pre-seed round; no specific funding amounts, dates, or lead investors have been publicly confirmed.

For investors, the primary signal is the founder's domain expertise in a niche where regulatory and scientific complexity creates a clear pain point. The next 12-18 months will be critical for validating whether the platform's AI can deliver tangible workflow acceleration for paying customers, moving beyond conceptual promise to documented deployments and initial revenue. The competitive and market context remains thinly detailed in public sources, making customer acquisition and product differentiation key unknowns to track. Data Accuracy: YELLOW -- Founder background and product concept confirmed by multiple sources; funding, traction, and market details lack independent corroboration.

Taxonomy Snapshot

Axis	Value
Stage	Pre-Seed
Business Model	SaaS
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	North America
Founding Team	Co-Founders (2)

Company Overview

PUBLIC

IngredientAI was founded in 2023 by Akash Shah, who serves as its Co-Founder and CEO [CRN USA, pre-2026]. The company is headquartered in New York, United States [The Org, 2026]. The founding narrative, as described by Shah, was inspired by the specific challenges of innovation and regulatory compliance within the dietary supplement and functional food industries, aiming to apply AI to surface insights from a vast corpus of scientific literature [CRN USA, pre-2026].

Shah's prior venture, the direct-to-consumer vitamin subscription company Care/of, which he co-founded in 2016, provides relevant operational context. Care/of raised a $12 million Series A in 2017, totaling $15 million in known funding, and Shah was recognized on the Forbes 30 Under 30 list in 2018 for this work [Forbes, 2018] [TechCrunch, 2024]. The company's closure in 2024 marks a pivot point, with IngredientAI representing a shift from a consumer-facing brand to a B2B software platform serving the upstream ingredient and formulation ecosystem.

Public milestones beyond the founding date are sparse. The company's website and a profile on The Org list Jonathan O. as Head of Product & Sales Operations, a role he reportedly began in September 2024 [The Org, 2026]. No other named executive team members, funding announcements, or significant partnership launches have been publicly documented in major business or trade press.

Data Accuracy: YELLOW -- Founding year and CEO role are confirmed; early team addition is from a single source. No independent verification of corporate status or other milestones.

Product and Technology

MIXED IngredientAI's core proposition is a research acceleration platform for the dietary supplement and functional food industries. The company describes its product as using AI to surface insights from what it claims are tens of millions of scientific studies, aiming to replace manual literature reviews with a more automated process for tasks like ingredient discovery, claims substantiation, and formulation research [CRN USA, pre-2026]. This positions the tool as a compliance and innovation aid for brands and ingredient suppliers, with the stated goal of helping them launch new products faster [Tola Capital, 2026].

The platform appears to offer at least two distinct functional surfaces. Research and dossier generation. The primary tool allows users to query a large corpus of studies to synthesize information and generate compliant research dossiers [CRN USA, pre-2026]. Supplier matching. A secondary feature uses AI to connect product developers with potential ingredient suppliers, acting as a marketplace facilitator [CRN USA, pre-2026]. The technology stack is not detailed in public materials, but the reliance on processing millions of documents suggests a foundation in natural language processing and knowledge graph construction (inferred from product claims).

Public details on the product's interface, specific AI models, data sources, or integration capabilities are absent. There is no mention of a public API, pre-built connectors to regulatory databases, or live customer deployments. The product's current state and feature completeness are inferred solely from high-level descriptions in a single trade interview and a brief portfolio page.

Data Accuracy: YELLOW -- Product claims are sourced from a single trade publication interview and an investor's portfolio page; technical implementation and feature details are not independently verified.

Market Research and Opportunity

PUBLIC

The market for AI in food and supplement innovation is emerging from a convergence of consumer demand for personalized health solutions and a historically inefficient R&D process.

Quantitative sizing for the specific niche of AI-driven ingredient discovery and formulation is not yet established in public analyst reports. However, analogous markets provide a frame of reference. The broader global dietary supplements market was valued at approximately $164 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.5% through 2030, according to Grand View Research [Grand View Research, 2024]. The functional food and beverage market is similarly sized, with Precedence Research estimating it at $275 billion in 2023 and growing at a CAGR of 8.8% [Precedence Research, 2024]. These figures represent the total addressable market (TAM) for the end products IngredientAI's customers aim to create. The serviceable addressable market (SAM) for AI-powered research tools within this sector is a smaller, undefined subset, likely tied to the R&D budgets of supplement brands and ingredient suppliers.

Several demand drivers are creating tailwinds for technology that can accelerate and de-risk innovation. Consumer interest in science-backed, personalized nutrition continues to rise, pushing brands to substantiate health claims with clinical research, a process cited as a core use case for the platform [CRN USA, pre-2026]. Simultaneously, the pace of scientific publication is accelerating, creating an information overload that manual research cannot efficiently parse. The platform's proposed value proposition directly addresses this bottleneck by surfacing insights from "tens of millions of studies" [CRN USA, pre-2026]. A third driver is supply chain complexity; the platform's mentioned supplier matching feature suggests an aim to streamline the connection between ingredient innovators and manufacturers seeking novel, compliant inputs [CRN USA, pre-2026].

Key adjacent and substitute markets include traditional consulting and research services, as well as broader enterprise AI platforms. Brands historically relied on internal R&D teams, academic partnerships, or specialized consultancies for formulation and claims work. The primary substitute is this manual labor. Adjacent markets include AI platforms for drug discovery (e.g., Recursion, Exscientia) and food tech companies applying AI to novel protein or ingredient creation, such as Shiru and Nuritas [Food Dive]. While these operate in different end markets (pharma, alternative proteins), they validate the application of AI to complex biological discovery and face similar challenges in translating computational predictions into commercial products.

Regulatory forces are a defining macro factor. The dietary supplement industry in the United States is governed by the FDA under the Dietary Supplement Health and Education Act (DSHEA), which places the onus for safety and labeling compliance on manufacturers. Navigating New Dietary Ingredient (NDI) notifications and structure/function claim substantiation is a significant hurdle. Any AI tool operating in this space must be built with a deep understanding of these compliance requirements to be credible. The company's early positioning acknowledges this, framing its AI as enabling "compliant research" [CRN USA, pre-2026].

Market Segment	2023 Size (Estimated)	Projected CAGR	Source
Global Dietary Supplements	~$164B	8.5%	Grand View Research, 2024
Global Functional Foods & Beverages	~$275B	8.8%	Precedence Research, 2024

This sizing data illustrates the substantial economic activity in the end markets IngredientAI aims to serve. The growth rates suggest a receptive environment for tools that can improve innovation efficiency. However, the translation from these large TAM figures to a viable SAM for a pre-revenue SaaS tool remains the central, unquantified challenge.

Data Accuracy: YELLOW -- Market sizing is drawn from third-party analyst reports for analogous sectors, not the specific AI tool niche. Demand drivers are inferred from industry trends and a single founder interview.

Competitive Landscape

MIXED

IngredientAI enters a market where established players are defined by their data assets and scientific validation, not just their AI models.

Company	Positioning	Stage / Funding	Notable Differentiator	Source
IngredientAI	AI platform for dietary supplement & functional food innovation, focusing on research synthesis and supplier matching.	Pre-Seed / Undisclosed [PUBLIC]	Founder's domain experience from Care/of; focus on supplement industry compliance and speed-to-market.	[CRN USA, pre-2026], [Tola Capital, 2026]
Brightseed	AI for discovering bioactive compounds in plants for health and nutrition applications.	Venture Capital-backed; $68M in total funding (estimated) [PUBLIC].	Proprietary Forager AI platform and bioscience validation pipeline; partnerships with major CPG companies.	[Food Dive, 2024]

This initial map reveals a fragmented competitive field. IngredientAI's stated focus is narrower than some AI-driven discovery platforms, concentrating specifically on the dietary supplement and functional food vertical. Its primary competition comes from two distinct archetypes. First, broad-spectrum AI discovery platforms like Brightseed and Nuritas, which use AI to identify novel bioactive compounds from natural sources and have secured significant venture funding and enterprise partnerships [Food Dive, 2024]. Their differentiator is a closed loop of computational discovery and lab validation, creating proprietary intellectual property. Second, incumbent data and service providers, such as subscription databases (e.g., Mintel GNPD) and consulting firms, which offer market intelligence and regulatory insights but lack AI-native synthesis. IngredientAI positions itself between these two, aiming to automate the research and matching processes that currently rely on manual effort.

Where IngredientAI claims a defensible edge today is in founder Akash Shah's specific domain experience. His background co-founding Care/of, a direct-to-consumer vitamin company, provides firsthand insight into the product development and compliance challenges of the supplement industry [Forbes, 2018]. This founder-market fit is a perishable advantage, however. It must be rapidly converted into a proprietary data asset,specifically, a corpus of studies and supplier information uniquely structured for AI queries,or a network effect among brands and suppliers. The company's early description of "surfacing insights from tens of millions of studies" suggests a data aggregation play, but the defensibility hinges on how uniquely that data is curated and linked for the supplement niche [CRN USA, pre-2026].

The exposure is acute in scientific validation and scale. A platform like Brightseed's Forager AI is coupled with a bioscience team to experimentally validate its AI-predicted compounds, a resource-intensive capability that lends credibility with large manufacturers [Food Dive, 2024]. IngredientAI's initial toolset, as described, appears focused on the earlier-stage research and sourcing workflow, not on de novo discovery or clinical claims support. This limits its addressable market to innovation teams rather than R&D divisions, and it may struggle to command similar price points. Furthermore, the company has no disclosed funding, while competitors in the adjacent bio-discovery space have raised tens of millions, enabling them to invest in both technology and scientific partnerships [Food Dive, 2024].

The most plausible 18-month scenario is one of segmentation. If IngredientAI can quickly onboard a cohort of early-adopter brands and use those relationships to refine its supplier matching engine, it could carve out a sustainable niche as a sourcing and compliance acceleration tool. The "winner" in this case would be a company like Brightseed, if it successfully expands from ingredient discovery into the broader product formulation workflow that IngredientAI is targeting. The "loser" would be generic market intelligence platforms that fail to offer industry-specific, AI-driven synthesis, ceding ground to vertical specialists. For IngredientAI, the critical near-term risk is being outflanked by a better-funded discovery platform that adds a formulation module, or by a legacy industry data provider that acquires an AI startup to modernize its offering.

Data Accuracy: YELLOW -- Competitor Brightseed's profile is confirmed by trade press; IngredientAI's positioning is based on limited company statements and founder interviews.

Opportunity

PUBLIC

If IngredientAI can successfully translate its founder's domain experience into a scalable software wedge, the company could become the primary research and sourcing intelligence layer for a global functional ingredients market valued in the hundreds of billions.

The headline opportunity is a category-defining platform for ingredient discovery and substantiation. The company's core proposition is to automate the labor-intensive, high-stakes research process that underpins new product development in supplements and functional foods. This outcome is reachable because the problem is well-defined and persistent: the regulatory and scientific burden of launching compliant products is a known bottleneck, and the founder, Akash Shah, has direct experience with these challenges from his prior venture, Care/of [CRN USA, pre-2026]. The platform's proposed utility,surfacing insights from tens of millions of studies,targets a fundamental inefficiency, positioning it as a potential default tool for R&D teams seeking to accelerate innovation while managing compliance risk.

Several concrete growth scenarios could propel the company from its current pre-seed stage to significant scale. The following table outlines two plausible paths.

Scenario	What happens	Catalyst	Why it's plausible
The Supplier Network Wedge	IngredientAI becomes the essential marketplace connecting brands with vetted ingredient suppliers.	The launch and adoption of its AI-powered supplier matching tool, as cited in company descriptions [CRN USA, pre-2026].	The platform starts with research, creating a natural funnel of qualified buyers. Adding transactional or lead-gen capabilities builds a two-sided network, a proven model in B2B commerce.
The Regulatory Compliance Standard	The company's dossier generation becomes the de facto method for assembling regulatory submissions for new dietary ingredients (NDIs) or health claims.	A strategic partnership with a major trade organization like the Council for Responsible Nutrition (CRN), where Shah has already been featured [Council for Responsible Nutrition, 2024].	The founder's established credibility within the industry trade group provides a potential channel for evangelizing and standardizing a software-driven approach to a manual, costly process.

Compounding success in this space would likely manifest as a data and workflow moat. Each formulation query, dossier generation, and supplier interaction would enrich the platform's proprietary dataset on ingredient efficacy, regulatory status, and commercial availability. This creates a classic flywheel: more users generate more proprietary data, which improves the accuracy and speed of the AI's insights, which in turn attracts more users and locks them into the platform for ongoing research needs. While there is no public evidence this flywheel is yet in motion, the product's design,centered on aggregating and synthesizing fragmented public and proprietary data,is inherently geared to create such an advantage.

The size of the win can be framed by looking at a credible, albeit broader, comparable. Brightseed, a competitor using AI for bioactive compound discovery, has raised over $100 million to date [Food Dive, 2023]. While Brightseed operates further upstream in the discovery pipeline, its valuation reflects the significant capital appetite for AI-driven solutions in the food and health ingredient sector. If IngredientAI executes on the Supplier Network Wedge scenario, capturing a material portion of the B2B sourcing and intelligence market, it could plausibly reach a similar scale of financing and enterprise value. This outcome represents a scenario, not a forecast, but it illustrates the magnitude of the opportunity if the company can transition from a promising tool to an indispensable industry platform.

Data Accuracy: YELLOW -- Core opportunity thesis is inferred from founder background and stated product direction; specific market size and competitive valuation benchmarks are not publicly available for this niche.

Sources

PUBLIC

1. [CRN USA, pre-2026] AI in Action: Revolutionizing Product Innovation and Compliance | https://crnusa.org/CRN-Experts-Explain/Akash-Shah-IngredientAI

2. [The Org, 2026] IngredientAI | https://theorg.com/org/ingredientai

3. [TechCrunch, 2024] Subscription vitamin company Care/of is shutting down | https://techcrunch.com/2024/06/15/subscription-vitamin-company-care-of-is-shutting-down/

4. [Forbes, 2018] Akash Shah | https://www.forbes.com/profile/akash-shah/

5. [Tola Capital, 2026] IngredientAI | https://tolacapital.com/portfolio/ingredientai

6. [PitchBook, 2026] IngredientAI 2026 Company Profile: Valuation, Funding & Investors | https://pitchbook.com/profiles/company/702341-20

7. [Food Dive, 2024] AI is raising the stakes in functional ingredient formulation | https://www.fooddive.com/news/food-science-ingredient-innovation-ai-nuritas-functional/815872/

8. [Grand View Research, 2024] Dietary Supplements Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/dietary-supplements-market

9. [Precedence Research, 2024] Functional Food Market Size, Growth, Report 2024-2033 | https://www.precedenceresearch.com/functional-food-market

10. [Council for Responsible Nutrition, 2024] CRN Experts Explain: Akash Shah, IngredientAI | https://crnusa.org/CRN-Experts-Explain/Akash-Shah-IngredientAI